NCT03010683View on ClinicalTrials.gov

Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

December 31, 2017

Conditions
Type 2 Diabetes MellitusCoronary Artery Disease
Interventions
DRUG

Liraglutide

Stimulation of Glucagon like peptide-1 receptor by liraglutide (Victoza) 1.8mg once daily as a subcutaneous injection

DRUG

Metformin

Antidiabetic drug-biguanide class (Glucophage) 1000mg twice daily per os

Trial Locations (1)

12462

''Attikon'' University General Hospital, Athens

All Listed Sponsors
lead

University of Athens

OTHER

NCT03010683 - Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus | Biotech Hunter | Biotech Hunter